Lidgard Graham Peter

Avg. Two Year Performance

No purchase track record
(89%) Avg. Sale Return
(38%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return(1%)(10%)(24%)(53%)(89%)
Sale Success Rate10 of 228 of 224 of 224 of 227 of 22
Drugs » Biotechnology

Sr. VP R&D, CTO:

Holdings: 59.62K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Chief Science Officer:

Holdings: 55.89K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--